<DOC>
	<DOC>NCT00000320</DOC>
	<brief_summary>The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form."</brief_summary>
	<brief_title>Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1</brief_title>
	<detailed_description>1) Compare subjects response to liquid vs tablet formulation 2) Assess bioequivalency of liquid vs tablet 3)Compare subject preference 4) Evaluate if dose response curve for tablet = to liquid form</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F ages 1865. Meet DMSIV criteria for opiate dependence. Agree to conditions of the study and sign informed consent. Pregnant or nursing women. Acute medical condition that would interfere with study participation or put safety of subjects in jeopardy. Current daily use of anticonvulsants, antabuse or neuroleptics. DSMIV diagnosis of ETOH or sedative/hypnotics dependence.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>opioid dependence</keyword>
</DOC>